leisure time -WSS

leisure time

author：hotspot 2025-08-12 11:29:19 - browse：1

Adobe

The medical device industry is split on whether a proposed new Medicare reimbursement pathway will do anything to soothe their insurance coverage woes.

Device makers have long complained that the unclear, rocky road to payment kills innovative companies. So they were thrilled when the Trump administration proposed a rule that would have guaranteed four years of Medicare coverage of approved devices deemed “breakthroughs” by the Food and Drug Administration. They hoped private payers would follow suit. But in 2021, under a new administration and a push for more device scrutiny, the Centers for Medicare and Medicaid pulled back on the idea, promising a replacement that would streamline coverage for innovative devices while ensuring safe, high-quality care.

The pathway put forth last week, called Transitional Coverage for Emerging Technologies (TCET), is only a notice, not yet a rule that would grant CMS new powers. The program applies solely to devices that have earned a place in the FDA’s breakthrough device program, which was established to identify devices that the agency believed could provide “more effective” treatment or diagnosis of serious conditions than the current standard of care. But because those devices can be brought to market with less certainty in their benefits and risks than other products, experts said, the idea of automatic reimbursement was dicey.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban
Next article： Live blog: Hearing on CRISPR

focus

WSS

Humans aren't the only ones with an imagination. Rats have it too

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

Stroke deaths set to near 10 million globally by 2050

Kidney transplant patients stopped immunosuppressants in trial

Liquid biopsy for lung cancer is launched by Delfi

Brain injuries and the importance of a second opinion

focus

leisure time

hotspot

Supreme Court strikes down use of affirmative action

Medicare proceeds with plan to claw back hospital funds

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Stroke deaths set to near 10 million globally by 2050

23andMe had bad news about my health. I wish a person had delivered it

Physician executives need more than on

After affirmative action ruling, medical educators look to 'holistic review'

After Sarepta trial failure, Duchenne families brace for more debate

BioMarin wins approval for gene therapy to treat hemophilia A

FDA authorizes Novavax’s updated Covid

leisure time

Medicare proceeds with plan to claw back hospital funds

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Why age limits for politicians are a terrible idea

Infant mortality in U.S. rose last year for first time in decades: CDC

Sarepta Duchenne therapy fails to meet primary endpoint in trial

How neuroscience research could help beat back brain cancer

leisure time

knowledge

focus

focus